A literature review on effective risk communication for the prevention and control of communicable diseases in Europe
This review brings together the current body of literature on risk communication (focused on communicable diseases) in a concise reference document which can be used to inform the development of evidence-based risk communication strategies and approaches. The review demonstrates that there is an impressive body of literature on risk communication relevant to the prevention and control of communicable diseases. This literature is complicated, however, by blurred definitions and overlap between risk communication and crisis communication. It is also widely dispersed across academic disciplines, lacking rigorous empirical evidence to demonstrate effectiveness, challenged by the complex and unpredictable ways that individuals perceive risk and the environmental, social, cultural and linguistic factors through which risk communication is viewed.
Risk communication is seen as one of the essential ways of limiting morbidity and mortality, as well as the damage to national economies and public health infrastructure caused by communicable diseases.
This review highlights the particular challenges faced by a multi-cultural and multi-lingual Europe when designing effective risk communication strategies. National and international collaboration is identified as being vital to deal with these challenges as well as further development of cross-sectoral risk preparedness strategies. Although there are many resources available to risk communicators today, limitations have been exposed once they have been tested. Gaps which the report identified include risk communication messages often failing to reach the intended targets and a lack of resources to meet the new and changing needs of more web-based societies.
External quality assessment scheme for Bordetella pertussis serology - 2020 data
28 Apr 2022 - This report presents the results of the ECDC European Reference Laboratory Network for Pertussis (ERLNPert-Net) external quality assessment (EQA) scheme for Bordetella pertussis PCR, funded by ECDC on behalf of ERLNPert-Net and conducted from April to September 2020. The EQA was organised by the National Institute for Biological Standards and Control (NIBSC), based in Potter’s Bar, United Kingdom (UK).
Public health considerations and evidence to support decisions on the implementation of a second mRNA COVID-19 vaccine booster dose
28 Apr 2022 - This document offers a more detailed overview of the available scientific and epidemiological evidence and public health considerations in order to support decisions on the implementation of a second booster dose of COVID-19 vaccine.
A scoping review of point-of-care testing devices for infectious disease surveillance, prevention and control
27 Apr 2022 - This document provides the final report of a scoping review undertaken as part of a wider study on the ‘Assessment of point of care testing devices for infectious disease surveillance, prevention and control’ that was commissioned by ECDC and undertaken by RAND Europe between November 2019 and April 2020.